European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Abstract Background and aim Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calciton...

Full description

Bibliographic Details
Main Authors: Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti
Format: Article
Language:English
Published: BMC 2019-01-01
Series:The Journal of Headache and Pain
Subjects:
Migraine
Chronic migraine
Prevention
Erenumab
Fremanezumab
Galcazenumab
Online Access:http://link.springer.com/article/10.1186/s10194-018-0955-y

Internet

http://link.springer.com/article/10.1186/s10194-018-0955-y

Similar Items